KabaFusion taps CareCloud for new AI platform LailaCare

SOMERSET, N.J., and LEXINGTON, Mass. – KabaFusion and CareCloud have announced a partnership to build LailaCare, a platform powered by artificial intelligence (AI) and designed to support and modernize KabaFusion's operations as a home infusion and specialty pharmacy provider. CareCloud will design and develop the platform, which will be owned by KabaFusion. "KabaFusion has spent years building a reputation for high quality, patient-centered infusion care, and we are always looking for ways to strengthen that foundation," said Dr. Sohail Masood, chairman and CEO of KabaFusion. "LailaCare is a natural next step for us. It will give our team the tools to work more efficiently and give our patients a more connected experience, while reinforcing the standard of care that has defined KabaFusion from the start." The two companies say LailaCare will unify workflows, including referral intake, eligibility and authorization, patient engagement, and revenue cycle management, into a single, integrated platform. They say the project is designed to reduce administrative burden and accelerate patient onboarding, while giving patients modern access to their own care journey. "CareCloud has spent 25 years building health care platforms at scale, and AI is now at the center of how we build," said Stephen Snyder, CEO of CareCloud. "LailaCare will pair KabaFusion's deep operational expertise in home infusion with CareCloud's technology and our AI Center of Excellence, exactly the kind of platform we are investing in, one designed to deliver measurable value to customers and to reflect the growing role of AI across our business." CareCloud says more than 40,000 providers count on solutions to help them improve patient care, while reducing administrative burdens and operating costs.

• Related: KabaFusion to accelerate growth with investment from Nautic Partners.